[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"University Maribor\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":99},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,45,73],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100652762","effects-of-kefir-on-celiac-disease-100652762",false,"NCT07777666","Effects of Kefir on Celiac Disease","Effects of Kefir Consumption on Celiac Disease Symptoms","CeliKef","Inclusion Criteria:\n\n* Adults aged 18 years or older with a confirmed diagnosis of celiac disease.\n* Following a strict gluten-free diet.\n\nExclusion Criteria:\n\n* Other chronic gastrointestinal diseases.\n* Pregnancy.\n* Known allergy or intolerance to milk or dairy products or other components of kefir.","ALL","18 Years",{"count":20,"type":21},30,"ESTIMATED","INTERVENTIONAL",[24],"NA","This study will investigate whether regular consumption of kefir can reduce gastrointestinal symptoms and improve quality of life in adults with celiac disease who follow a strict gluten-free diet. The study will use a randomized cross-over design in which participants will consume kefir during one study period and continue their usual diet without kefir during another period.",[27],"Celiac Disease",[29,30,31],"celiac disease","kefir","gluten","NOT_YET_RECRUITING","2026-08-17",{"date":35,"type":36},"2026-08-20","ACTUAL",{"date":38,"type":21},"2026-09-30",{"date":40,"type":21},"2027-11-29",{"name":42,"class":43},"University Maribor","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":53,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":54,"targetDuration":4,"studyType":22,"phases":56,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":44},"100608358","effect-of-probiotics-after-neurosurgery-100608358","NCT07200518","Effect of Probiotics After Neurosurgery","The Multistrain Probiotic OMNi-BiOTiC® Hetox for Treatment After Neurosurgery (ProSURG)","ProSURG","Inclusion Criteria:\n\n* adults with MRI-confirmed disc herniation, stenosis, or instability of the lumbar or cervical spine.\n* Able to provide written informed consent\n* Willing to comply with study procedures and follow-up assessments\n* No contraindications to probiotic administration\n\nExclusion Criteria:\n\n* symptoms of acute infection (vomiting, fever above 38°C, diarrhea, respiratory symptoms),\n* chronic diseases,\n* use of probiotics one month before inclusion.",true,{"count":55,"type":21},110,[24],"The goal of this randomised controlled trial is to determine the effect of consuming a multistrain probiotic OMNi-BiOTiC® Hetox on improving the healing, pain management, and postsurgical complications after neurosurgery.\n\nThe main question it aims to answer is:\n\n• Is the multistrain probiotic OMNi-BiOTiC® Hetox effective in in improving patient-reported disability after neurosurgery?\n\nResearchers will compare the probiotic group and the placebo group to determine if the healing is significantly different between the groups.",[59],"Healing",[61,62,63],"neurosurgery","probiotics","Omni-Biotic Hetox","RECRUITING","2025-11-21",{"date":67,"type":36},"2025-11-28",{"date":69,"type":36},"2025-11-03",{"date":71,"type":21},"2027-06-01",{"name":42,"class":43},{"id":74,"slug":75,"hasResults":11,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":79,"eligibilityCriteria":80,"healthyVolunteers":11,"sex":17,"minAge":81,"maxAge":82,"enrollmentInfo":83,"targetDuration":4,"studyType":22,"phases":85,"briefSummary":86,"conditions":87,"keywords":89,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":92,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":44},"100574132","probiotics-for-diaper-dermatitis-100574132","NCT06755307","Probiotics for Diaper Dermatitis","PROBIOTICS FOR TREATING DIAPER DERMATITIS IN CHILDREN - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL","ProDiaper II","Inclusion Criteria:\n\n* presence of diaper dermatitis\n* age less than two years\n\nExclusion Criteria:\n\n* previous use of probiotics\n* age more than two years\n* an acute bacterial infection\n* chronic disease\n* local use of antibiotics in the anogenital region","1 Month","2 Years",{"count":84,"type":21},42,[24],"The goal of this randomized controlled clinical trial is to determine the effect of the probiotic OMNiBiOTiC® Panda in treating diaper dermatitis in children under the age of two years. The main question it aims to answer is:\n\nIs the probiotic OMNiBiOTiC® Panda effective in reducing the duration of diaper dermatitis in children under the age of two years?\n\nResearchers will compare the probiotic and placebo group to see if the duration of diaper dermatitis is significant among the two groups.\n\nParticipants will:\n\n* receive 6 droplets daily of probiotic or placebo for 3 weeks and\n* observe and record improvement of diaper rash symptoms each day using a diary.",[88],"Diaper Dermatitis",[90,62,91],"diaper dermatitis","children",{"date":93,"type":36},"2025-11-24",{"date":95,"type":36},"2025-08-14",{"date":97,"type":21},"2026-03-01",{"name":42,"class":43},""]